News

Rob Patterson Takes Charge as Head of Data at Barclays

Rob Patterson Takes Charge as Head of Data at Barclays

Barclays Appoints Rob Patterson as Head of Data & Information Platforms

Barclays has made a significant leadership choice by appointing Rob Patterson as the new Head of Data & Information Platforms Coverage within its Technology Investment Banking division. This strategic move aims to strengthen the bank's capabilities in this vital area.

Rob Patterson: A Seasoned Leader Joins Barclays

Patterson brings nearly twenty years of experience from Morgan Stanley, where he served as a Managing Director overseeing Marketing, Information, and Technology-enabled Services Investment Banking. His extensive background includes executing high-profile mergers, acquisitions, and capital markets transactions with top firms in the industry.

Patterson's Previous Accomplishments

While at Morgan Stanley, Patterson played a significant role in transactions involving esteemed clients like Accenture, Nielsen, and PWC, demonstrating his proficiency in managing complex deals. His in-depth knowledge of the industry and established relationships uniquely position him to guide Barclays into a new phase in the data and information sector.

Focused on Growth in Technology Investment Banking

Patterson’s hiring is part of Barclays’ larger strategy to enhance its Technology Investment Banking division by bringing in top talent. Kristin Roth DeClark, the Global Head of Technology Investment Banking, expressed her confidence in Patterson’s abilities, emphasizing his leadership skills and extensive connections in the industry.

Other Recent High-Profile Hires

Alongside Patterson, David King has recently joined Barclays as the Global Head of Technology M&A, further enhancing the bank’s robust team in this area. These strategic hires are crucial for maintaining a competitive edge in today’s rapidly evolving market.

Major Transactions by Barclays

Barclays has established a strong presence in the Technology Investment Banking sector through several key transactions. Recently, they served as Lead Financial Advisor in the acquisition of a significant stake in Epicor by CD&R.

Additionally, Barclays acted as the Exclusive Financial Advisor for Nuvei Corporation in its impressive $6.3 billion sale to Advent International, marking a notable success for the investment banking group.

The Importance of the Arm IPO

A standout moment for Barclays was leading the IPO of Arm, which raised $4.9 billion. This IPO is recognized as the largest since 2021 and underscores Barclays’ strong standing in the market.

Understanding Barclays and Its Operations

Barclays is a universal bank based in the UK, providing a wide array of financial services around the globe. Its operations include consumer banking, payments, and investment banking, highlighting its significant presence in the financial services sector.

Corporate and Investment Banking at Barclays

The Corporate and Investment Banking division at Barclays integrates various services such as Investment Banking, International Corporate Banking, and Global Markets. This division serves a diverse range of clients, including government agencies and multinational corporations, each requiring tailored funding and strategic solutions.

Frequently Asked Questions

Who is Rob Patterson?

Rob Patterson is the newly appointed Head of Data & Information Platforms Coverage at Barclays Technology Investment Banking.

What prior experience does Rob Patterson have?

Patterson has nearly 20 years of experience at Morgan Stanley, specializing in technology-enabled services and leading significant transactions.

Why is Patterson's appointment significant?

His deep industry knowledge and established relationships are expected to enhance Barclays' capabilities in Data & Information platforms.

What other strategic hires has Barclays made recently?

David King has also been appointed as Global Head of Technology M&A, contributing to the bank's strong team.

What are some recent transactions by Barclays?

Barclays has acted as Lead Financial Advisor in notable deals including Epicor's acquisition and Nuvei's sale to Advent International.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

ROKFORM’s Signal Card: A Wallet Tracker for All

Updated Category News Views 10

The Gadget You Didn't Know You Needed Ever feel that momentary panic when your wallet seems to have vanished into thin air? ROKFORM's fresh offering, the Signal Card, tackles that heart-stopping moment head-on. They've taken the mundane act of misplacing your wallet and transformed it with their sleek, credit-card-sized tracker. This baby pairs seamlessly with Apple Find...

Continue Reading
Cure Blindness Project's 770K Screenings for World Sight Day

Updated Category News Views 17

Visionary Steps Toward a Brighter Future No two words could describe the task that Cure Blindness Project is tackling this year: vision and action. Marking World Sight Day on October 8, they plan to usher in 770,000 eye screenings across Asia, Africa, and the Caribbean. These initiatives aren't just numbers—they're a colossal step toward lifting the veil of avoidable...

Continue Reading
Purina Institute Highlights Nutritional Science at WSAVA 2026

Updated Category News Views 17

A Global Stage for Pet Nutrition Science The folks over at the Purina Institute are back in the spotlight as they gear up to throw their weight behind the 51st World Small Animal Veterinary Association (WSAVA) Congress in Warsaw, Poland. Set for October 13-15, 2026, this isn’t just another event—they're bringing some serious clout with their 'Food for Thought'...

Continue Reading
TA Services Strengthens U.S.-Mexico Freight Operations

Updated Category News Views 17

TA Services Moves Boldly Across Borders If ever there was a time to play the logistics chessboard like a champ, it's now, and TA Services just slammed the board with a solid move. They've grabbed Carmen Pacheco Transportation and Interload Forwarding, two family-run operations with some real muscle in North American logistics. This isn't a small-time maneuver; they've...

Continue Reading
Navigating Holiday Sweets: Healthy Balancing Acts

Updated Category News Views 14

In the middle of the sweet madness that is the holiday season, Crispy Green and Dr. Nicole Avena are playing guide to families drowning in sugar. This isn't just a once-a-year Halloween headache; we're starting that sugar spiral early and letting it ride until the New Year approaches. It's an all-hands-on-deck situation if families want to dodge that sugar overload. Why...

Continue Reading
Cala Launches Game-Changer Wearable for Tremor Relief

Updated Category News Views 11

Breaking New Ground in Neuromodulation Medical tech's on a roll, and Cala Health just hopped on the fast track with their latest launch—the Cala kIQ Plus System. This bad boy is aiming to offer relief for those grappling with hand tremors, thanks to its FDA clearance and a host of new features. It's the first of its kind, combining multiple therapy modes with an...

Continue Reading
Karoo Health Leaps Forward with New CCO Breton

Updated Category News Views 13

Change of Guard in Cardiac Health at Karoo Here's a move that might shake things up in the healthtech sector: Karoo Health just snagged Angela "Angie" Breton as their new Chief Commercial Officer. It's like putting a seasoned captain at the helm right before setting sail on uncharted waters. Breton's not just any captain—she's got a hefty 25 years of experience...

Continue Reading
Community Banks Missing $106B Lending Opportunity?

Updated Category News Views 19

A Missed Opportunity for Community Banks It's a classic tale: community banks sleepwalking while big players snatch up low-hanging fruit right in their own backyards. According to the latest report by Cornerstone Advisors, commissioned by Teslar Software, these banks are essentially leaving $106 billion on the table when it comes to consumer lending. That's not just chump...

Continue Reading
Northern Jet Names Veteran Matthew Harris as CEO

Updated Category News Views 26

Fresh Leadership at Northern Jet Well, if you didn’t see this coming, you’ve been snoozing on the tarmac. Northern Jet, no stranger to the skies after three decades, just roped in Matthew Harris as their new CEO from October 2, 2026. They're pulling in this hotshot with more than 25 years riding the turbulence of private aviation. And listen to this: his marching...

Continue Reading
Skandia's Soundproofing Kit Expands to Brazil's Skies

Updated Category News Views 12

Soundproofing Takes Off in Brazil Skandia has just pulled off a neat trick, earning the nod from Brazil's National Civil Aviation Agency (ANAC) for their King Air soundproofing kit. That means quieter skies ahead for operators of the King Air 200 and 300 series in Brazil. This is no small feat, folks; it's like finally getting that coveted backstage pass after years of...

Continue Reading

Top 5 Most Recently Viewed Articles

Investor Alert: Tronox Shareholders Face Lead Plaintiff Deadline

Updated Category News Views 130

Investors Need to Act: Key Deadline for Tronox Shareholders Attention shareholders of Tronox Holdings plc (NYSE: TROX): it’s crucial to stay informed about your rights as an investor, especially regarding the recent lawsuit against the company. Understanding the Allegations During a specified period, shareholders of TROX were encouraged to keep a close watch on...

Continue Reading
Investors Urged to Act on Crocs Class Action Lawsuit Claims

Updated Category News Views 226

Understanding the Crocs Class Action Lawsuit Recently, a call to action has been made for investors affected by stock losses in Crocs, Inc. This is crucial for those who have faced losses exceeding $100,000. Investors are reminded that there is a lead plaintiff application deadline approaching. This opportunity could be significant for shareholders of Crocs as they...

Continue Reading
Mullen Group's Third Quarter Growth Fueled by Strategic Acquisitions

Updated Category News Views 133

Mullen Group's Thriving Growth in Acquisitions In the latest quarter, Mullen Group Ltd. (TSX: MTL) demonstrated strong growth driven by its strategic acquisition initiatives. As major logistics provider in Canada, Mullen Group continues to adapt and thrive, successfully navigating the complex currents of a challenging economic environment. Their comparative financial...

Continue Reading
Stay Informed: Lantheus Holdings Legal Action Updates

Updated Category News Views 149

Understanding the Recent Legal Matters Surrounding Lantheus Holdings Lantheus Holdings, Inc. (NASDAQ: LNTH) has recently been in the spotlight due to a securities class action lawsuit. The Rosen Law Firm aims to remind investors who purchased Lantheus securities between specific dates to take swift action in securing legal representation. Why You Should Act Now If you...

Continue Reading
Corbus Pharmaceuticals (CRBP) Faces Setback Amid Market Concerns

Updated Category News Views 143

Corbus Pharmaceuticals (CRBP) Faces Stock Market Challenges Recently, Corbus Pharmaceuticals (CRBP) saw its stock take a steep dive, falling nearly 60% from its previous value of $52 down to $21. This drop was largely spurred by disappointing trial results from Novo Nordisk regarding their cannabinoid-based weight loss medication, monlunabant. Competitors in the...

Continue Reading